Intrahepatic Sarcomatoid Cholangiocarcinoma

Table 1

Clinicopathological features of previously published patients with sarcomatoid cholangiocarcinoma.

	no. of patients	Sarcomatoid component	Treatment	Survival
Kaibori et al. [7]	1	Pleomorphic and spindle cells	Surgery	Patient died ≤3 months after surgery with recurrence
Sumiyoshi et al. [8]	1	Spindle cell	None	Patient died within 2 months after diagnosis
Sato et al. [2]	1	Round cell variant	None	Patient died within 3 months of diagnosis
Nakajima et al. [5]	7	Spindle cell (5)	Surgery (2)	- Patient died ≤3 months after diagnosis (4)
		Pleomorphic and spindle cell (2)	TAE (2)	- Patient died 3–6 months after diagnosis (2)
			Chemotherapy* (1)	- Patient alive beyond 6 months (1)
			None (2)
Aishima et al. [3]	7	Not available	Surgery (7)	5 patients died of disease recurrence. 3 year survival (17.9%)

TAE (Trans arterial chemoembolisation), *details of chemotherapy not available.